The Department of Pathology offers a one-year fellowship in soft tissue pathology. The goal is to provide an extensive and immersive experience in soft tissue pathology. The focus of this fellowship can vary with the interests of the individual, but the fellow will be responsible for:
- Previewing and establishing the diagnosis for cases seen in the department (in-house biopsies, resections, referrals and consults)
- Assisting in gross examination of complex surgical resection specimens
- Correlating the results of cytogenetics and molecular testing with the final diagnosis
- Interacting with clinical colleagues to obtain additional pertinent clinical information and support the multidisciplinary conferences
- Developing at least one major academic project leading to submission for publication
Resources for presentation at a national meeting and attendance at a soft tissue course in November are provided.
MD Anderson is the largest sarcoma treatment center in the United States and provides a uniquely rich opportunity for clinicopathologic correlation with soft tissue tumors and for translational research. Well in excess of 3,000 soft tissue tumors (benign and malignant) are examined at MD Anderson each year.
The broad range of pathologic material available and the large consultation services of several of our faculty is an excellent source for learning diagnostic skills and the clinical aspects of these tumors and their treatment. This extensive experience will allow the fellow to obtain strong skills in the diagnosis and multidisciplinary treatment of these tumors.
Rotations in the cytogenetics and molecular diagnostics labs and continual involvement with the sarcoma molecular diagnosis service are part of the fellowship. Ample time and resources are available for academic pursuits. Exposure to the bone sarcoma service can also be arranged.
Candidates must be board-certified or eligible for certification in Anatomic Pathology or AP/CP.
Please check complete GME Eligibility Requirements prior to applying.
December 31, 18 months prior to the start of the training year.
Commensurate with the candidate's level of training.
Alexander Lazar, M.D., Ph.D.
Program Director, Soft Tissue Pathology Fellowship
UT MD Anderson Cancer Center
1515 Holcombe Blvd.
Houston, TX 77030
For inquiries, please contact:
For inquiries of elective rotations, please email:
For inquiries of observerships, please email:
Verification of training
Requests for verification should be sent to:
MD Anderson Cancer Center is committed to encouraging good health and staying true to our mission to end cancer. If you are applying for a GME fellowship or residency program starting on or after July 1, 2016, please be advised that MD Anderson will have instituted a tobacco-free hiring process as part of its efforts to achieve these goals. If you are offered an appointment, you will be subject to a Pre-Employment Drug Screen for tobacco compounds in compliance with applicable state laws. If you do not pass the urine drug screening which includes testing for tobacco compounds, you CANNOT be appointed at MD Anderson. Should you fail to meet this contingency, MD Anderson will withdraw your offer of appointment for the academic year. You may reapply for the following academic year, but there are no guarantees that you will be offered a position as many of our programs are already filled for several years out.